Advertisement

Ads Placeholder
Loading...

Bio-Genex Laboratories, Inc.

BGNX•PNK
Healthcare
Medical - Diagnostics & Research
$0.00
$-0.00(-96.77%)
U.S. Market opens in 58h 2m

Bio-Genex Laboratories, Inc. (BGNX) Stock Overview

Explore Bio-Genex Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

BGNX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Genex Laboratories, Inc. (BGNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-96.77%
6-Month Change
-96.77%
Year-to-Date (YTD) Change
-96.77%
1-Year Change
-96.77%
3-Year Change
N/A
5-Year Change
900.00%
All-Time (Max) Change
N/A

Contact Information

NaN
63 2 567 5163
Pearl of the Orient Tower, Manila, NaN, NaN

Company Facts

IPO DateMar 21, 2013
CountryPH

Frequently Asked Questions